CE (Celanese Corporation Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by CE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Chuck Kyrish | SVP & CFO | Buy | — | — |
| 2026-08-13 | Ashley B Duffie | SVP & GC | Buy | — | — |
| 2026-08-12 | Kim K.W. Rucker | Director | A | — | — |
| 2026-08-12 | Kathryn Hill | Director | A | — | — |
| 2026-08-12 | Deborah J. Kissire | Director | A | — | — |
| 2026-08-12 | EDWARD G GALANTE | Director | A | — | — |
| 2026-08-12 | Mark Christopher Murray | SVP - Acetyls | Buy | — | — |
| 2026-05-13 | EDWARD G GALANTE | Director | A | — | — |
| 2026-05-13 | Christopher J Kuehn | Director | MIXED | — | — |
| 2026-05-13 | Kathryn Hill | Director | A | — | — |
| 2026-05-13 | Kim K.W. Rucker | Director | MIXED | — | — |
| 2026-05-13 | Deborah J. Kissire | Director | MIXED | — | — |
| 2026-05-13 | GANESH MOORTHY | Director | A | — | — |
| 2026-05-13 | Michael Koenig | Director | MIXED | — | — |
| 2026-05-13 | Anne P Noonan | Director | A | — | — |
| 2026-05-13 | Bruce E. Chinn | Director | A | — | — |
| 2026-03-11 | EDWARD G GALANTE | Director | A | — | — |
| 2026-03-11 | Kathryn Hill | Director | A | — | — |
| 2026-03-11 | JAY V IHLENFELD | Director | A | — | — |
| 2026-03-11 | Deborah J. Kissire | Director | A | — | — |
| 2026-03-11 | Kim K.W. Rucker | Director | A | — | — |
| 2026-03-03 | Ashley B Duffie | SVP & GC | A | — | — |
| 2026-03-03 | Todd L Elliott | SVP, EM | A | — | — |
| 2026-03-03 | Chuck Kyrish | SVP & CFO | A | — | — |
| 2026-03-03 | Aaron M McGilvray | Chief Accounting Officer | A | — | — |
| 2026-03-03 | Mark Christopher Murray | SVP - Acetyls | A | — | — |
| 2026-03-03 | Scott A Richardson | CEO & President | A | — | — |
| 2026-02-18 | Ashley B Duffie | SVP & GC | MIXED | — | — |
| 2026-02-18 | Chuck Kyrish | SVP & CFO | MIXED | — | — |
| 2026-02-18 | Aaron M McGilvray | Chief Accounting Officer | MIXED | — | — |
| 2026-02-18 | Mark Christopher Murray | SVP - Acetyls | MIXED | — | — |
| 2026-02-18 | Scott A Richardson | CEO & President | MIXED | — | — |
| 2026-01-30 | Kathryn Hill | Director | C | — | — |
| 2025-12-12 | Scott A Richardson | CEO & President | Buy | — | — |
| 2025-12-11 | Chuck Kyrish | SVP & CFO | Buy | — | — |
| 2025-11-19 | Ashley B Duffie | SVP & GC | A | — | — |
| 2025-11-19 | Aaron M McGilvray | Chief Accounting Officer | A | — | — |
| 2025-11-13 | EDWARD G GALANTE | Director | A | — | — |
| 2025-11-13 | Timothy Go | Director | A | — | — |
| 2025-11-13 | Kathryn Hill | Director | A | — | — |
| 2025-11-13 | JAY V IHLENFELD | Director | A | — | — |
| 2025-11-13 | Deborah J. Kissire | Director | A | — | — |
| 2025-11-13 | Kim K.W. Rucker | Director | A | — | — |
| 2025-09-09 | Timothy Go | Director | Buy | — | — |
| 2025-08-18 | EDWARD G GALANTE | Director | Buy | — | — |
| 2025-08-18 | GANESH MOORTHY | Director | Buy | — | — |
| 2025-08-18 | Scott McDougald Sutton | Director | Buy | — | — |
| 2025-08-18 | Mark Christopher Murray | SVP - Acetyls | Buy | — | — |
| 2025-08-13 | EDWARD G GALANTE | Director | A | — | — |
| 2025-08-13 | Timothy Go | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 13,647,621 | — |
| — | Chairman and CEO | 804,082 | — |
| — | EVP & President, Acetyls | 221,300 | — |
| — | Chairman and CEO | 181,040 | — |
| — | Chairman and CEO | 174,675 | — |
| — | SVP, Business Strategy Dev. | 169,350 | — |
| — | SVP, Operations & Technical | 128,621 | — |
| — | CEO & President | 124,014 | — |
| — | EVP, Supply Management | 94,353 | — |
| — | 10%+ Owner | 92,332 | — |
| — | Director | 77,677 | — |
| — | Director | 63,482 | — |
| — | SVP & CFO | 61,489 | — |
| — | SVP, EM | 57,023 | — |
| — | Director | 54,997 | — |
| — | Director | 54,760 | — |
| — | EVP and CFO | 53,982 | — |
| — | Executive Officer | 48,745 | — |
| — | Chief Operating Officer | 45,795 | — |
| — | EVP, General Counsel and Sec. | 45,600 | — |
| — | SVP, GC & Sec | 43,948 | — |
| — | SVP, EM | 39,388 | — |
| — | Director | 38,961 | — |
| — | Corporate EVP | 36,853 | — |
| — | SVP & GC | 32,616 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CE quote page; the site-wide leaderboard is on the insider transactions hub.